Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors

Published:2014-02 Issue:2 Volume:146 Page:453-460.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Marinoni Ilaria,Kurrer Anja Schmitt,Vassella Erik,Dettmer Matthias,Rudolph Thomas,Banz Vanessa,Hunger Fabio,Pasquinelli Silvan,Speel Ernst–Jan,Perren Aurel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors;Halfdanarson;Endocr Relat Cancer,2008

2. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group;Moertel;Cancer,1981

3. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors;Raymond;N Engl J Med,2011

4. Everolimus for advanced pancreatic neuroendocrine tumors;Yao;N Engl J Med,2011

5. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas;Strosberg;Cancer,2011

Cited by 369 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARX, PDX1, ISL1, and CDX2 Expression Distinguishes 5 Subgroups of Pancreatic Neuroendocrine Tumors With Correlations to Histology, Hormone Expression, and Outcome;Modern Pathology;2024-11

2. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications;Current Problems in Cancer;2024-10

3. Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors;Surgical Clinics of North America;2024-10

4. Pancreas Fine Needle Aspiration;Surgical Pathology Clinics;2024-09

5. Genomic Landscape of Pancreatic Neuroendocrine Tumors and Implications for Clinical Practice;JCO Precision Oncology;2024-09